0000000000042445

AUTHOR

Juan Salazar

showing 2 related works from this author

Advanced Glycation End Products: New Clinical and Molecular Perspectives

2021

Diabetes mellitus (DM) is considered one of the most massive epidemics of the twenty-first century due to its high mortality rates caused mainly due to its complications; therefore, the early identification of such complications becomes a race against time to establish a prompt diagnosis. The research of complications of DM over the years has allowed the development of numerous alternatives for diagnosis. Among these emerge the quantification of advanced glycation end products (AGEs) given their increased levels due to chronic hyperglycemia, while also being related to the induction of different stress-associated cellular responses and proinflammatory mechanisms involved in the progression …

Glycation End Products Advancedmedicine.medical_specialtyHealth Toxicology and Mutagenesis030209 endocrinology & metabolismReview030204 cardiovascular system & hematologyFluorescence03 medical and health sciences0302 clinical medicineChronic hyperglycemiaGlycationDiabetes mellitusskin fluorescencemedicineHumansIntensive care medicineSkinbusiness.industryadvanced glycation end productsHigh mortalityPublic Health Environmental and Occupational HealthRmedicine.diseasechronic complicationsHyperglycemiadiabetes mellitusMedicinebusinessInternational Journal of Environmental Research and Public Health
researchProduct

The Role of the α Cell in the Pathogenesis of Diabetes: A World beyond the Mirror

2021

Type 2 Diabetes Mellitus (T2DM) is one of the most prevalent chronic metabolic disorders, and insulin has been placed at the epicentre of its pathophysiological basis. However, the involvement of impaired alpha (α) cell function has been recognized as playing an essential role in several diseases, since hyperglucagonemia has been evidenced in both Type 1 and T2DM. This phenomenon has been attributed to intra-islet defects, like modifications in pancreatic α cell mass or dysfunction in glucagon’s secretion. Emerging evidence has shown that chronic hyperglycaemia provokes changes in the Langerhans’ islets cytoarchitecture, including α cell hyperplasia, pancreatic beta (β) cell dedifferentiati…

endocrine system diseasesmedicine.medical_treatmentReviewGlucagon-Like Peptide 1Insulin-Secreting CellsHyperglycaemiaBiology (General)SpectroscopyLangerhans’ isletsGlucagon secretionType 2 diabetesGeneral MedicineComputer Science ApplicationsChemistryAutocrine Communicationtype 2 diabeteshormones hormone substitutes and hormone antagonistsmedicine.medical_specialtyendocrine systemQH301-705.5GlucagonCatalysisInorganic ChemistryParacrine signallingInsulin resistanceInternal medicineDiabetes mellitusParacrine CommunicationmedicineAnimalsHumansHypoglycemic AgentsPhysical and Theoretical ChemistryQD1-999Molecular BiologyDipeptidyl-Peptidase IV Inhibitorsbusiness.industryInsulinOrganic ChemistryType 2 Diabetes Mellitusmedicine.diseaseGlucagonEndocrinologyDiabetes Mellitus Type 1Diabetes Mellitus Type 2Glucagon-Secreting CellsbusinessHypoglycaemiahyperglycaemiaHyperglucagonemiahypoglycaemiaInternational Journal of Molecular Sciences
researchProduct